| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |